[
  {
    "nct_id": "NCT05000021",
    "title": "Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2022-06-27",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT05000021"
  },
  {
    "nct_id": "NCT05734313",
    "title": "Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression in Young Adults With Type 1 Diabetes",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2023-03-31",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT05734313"
  },
  {
    "nct_id": "NCT05268250",
    "title": "Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2024-02-26",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT05268250"
  },
  {
    "nct_id": "NCT06325202",
    "title": "Closed Loop and Education for Hypoglycemia Awareness Restoration (CLEAR), Conducted by the Impaired Awareness of Hypoglycemia Consortium (IAHC)",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-10-03",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06325202"
  },
  {
    "nct_id": "NCT06405373",
    "title": "Fusing Rapid-cycle Testing and Adaptive Trial Designs: A Scientific Pipeline to Translate and Individualize Evidence-based Psychosocial and Behavioral Interventions in Routine Type 1 Diabetes Care",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2024-10-01",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06405373"
  },
  {
    "nct_id": "NCT06111586",
    "title": "A 52-week Randomized, Double-blind, Placebo-controlled, Multi-center Phase 2b Study With a 52-week Blinded Extension Assessing Safety and Efficacy of Frexalimab, a CD40L-antagonist Monoclonal Antibody, for Preservation of Pancreatic \u03b2-cell Function in Adults and Adolescents With Newly Diagnosed Type 1 Diabetes on Insulin Therapy",
    "phase": "PHASE2",
    "status": "RECRUITING",
    "start_date": "2023-12-11",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06111586"
  },
  {
    "nct_id": "NCT06791291",
    "title": "Efficacy and Safety of Teplizumab in the Treatment of Japanese Pediatric and Adult Participants Aged 8 to 34 Years With Stage 2 Type 1 Diabetes: A Multicenter, Randomized, Open-label, Controlled Study.",
    "phase": "PHASE2",
    "status": "RECRUITING",
    "start_date": "2025-07-25",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06791291"
  },
  {
    "nct_id": "NCT05018585",
    "title": "A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Diamyd\u00ae to Preserve Endogenous Beta Cell Function in Adolescents and Adults With Recently Diagnosed Type 1 Diabetes, Carrying the Genetic HLA DR3-DQ2 Haplotype",
    "phase": "PHASE3",
    "status": "RECRUITING",
    "start_date": "2022-05-19",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT05018585"
  },
  {
    "nct_id": "NCT06481904",
    "title": "An Observational, Long-term Safety Study of TZIELD\u00ae (Teplizumab-mzwv) in Patients With Stage 2 Type 1 Diabetes",
    "phase": "Unknown",
    "status": "RECRUITING",
    "start_date": "2024-09-27",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06481904"
  },
  {
    "nct_id": "NCT05540704",
    "title": "Changing the T1DE (Type 1 Disordered Eating): A Randomized Controlled Trial Comparing ACT to Supportive Diabetes Counseling",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2023-04-04",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT05540704"
  },
  {
    "nct_id": "NCT07104500",
    "title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 78-Week Efficacy and Safety Study of VK2735 Administered Subcutaneously for Weight Management in Participants Without Type 2 Diabetes Who Are Obese, or Overweight With at Least One Weight-related Comorbid Condition",
    "phase": "PHASE3",
    "status": "RECRUITING",
    "start_date": "2025-06-23",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07104500"
  },
  {
    "nct_id": "NCT06914895",
    "title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Tirzepatide Once Weekly Compared to Placebo in Adult Participants With Type 1 Diabetes and Obesity or Overweight",
    "phase": "PHASE3",
    "status": "RECRUITING",
    "start_date": "2025-04-25",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06914895"
  },
  {
    "nct_id": "NCT06845202",
    "title": "A Phase 1/2, Randomized, Double-blind, Placebo-controlled 2-part Study of the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Dose ALN-4324 in Overweight to Obese Adult Healthy Volunteers and Multiple Dose ALN-4324 in Overweight to Obese Patients With Type 2 Diabetes Mellitus (T2DM)",
    "phase": "PHASE1",
    "status": "RECRUITING",
    "start_date": "2025-03-03",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06845202"
  },
  {
    "nct_id": "NCT06972459",
    "title": "A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Participants With Obesity or Overweight With and Without Type 2 Diabetes",
    "phase": "PHASE3",
    "status": "RECRUITING",
    "start_date": "2025-05-15",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06972459"
  },
  {
    "nct_id": "NCT06962280",
    "title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Long-Term Safety of Tirzepatide Once Weekly Compared to Placebo in Adults With Type 1 Diabetes and Obesity or Overweight",
    "phase": "PHASE3",
    "status": "RECRUITING",
    "start_date": "2025-05-12",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06962280"
  },
  {
    "nct_id": "NCT05267626",
    "title": "A Phase 1/2, First-in-Human, Open Label, Dose Escalation and Expansion Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2R\u03b1 Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer",
    "phase": "PHASE1",
    "status": "RECRUITING",
    "start_date": "2022-04-04",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT05267626"
  },
  {
    "nct_id": "NCT06546930",
    "title": "Optimizing Diabetes Technology Use for Latinx Youth Through DREAM (Device Use Reimagined Through Education And Mentorship) Virtual Peer Groups [Study-wide] - DREAM Intervention",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2024-10-11",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06546930"
  },
  {
    "nct_id": "NCT07088068",
    "title": "A Randomized, Double-blind, 2-arm, Phase 3 Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Newly Diagnosed Stage 3 Type 1 Diabetes (T1D)",
    "phase": "PHASE3",
    "status": "RECRUITING",
    "start_date": "2025-08-06",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07088068"
  },
  {
    "nct_id": "NCT06807190",
    "title": "A Multi-centre, Prospective, Open Label, Non-interventional, Single-armed, 52 Weeks Post-marketing Study to Investigate Safety and Clinical Parameters of Awiqli Once Weekly in Patients With Diabetes Mellitus Under Real-world Clinical Practice Setting in Japan",
    "phase": "Unknown",
    "status": "RECRUITING",
    "start_date": "2025-04-15",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06807190"
  },
  {
    "nct_id": "NCT06919354",
    "title": "POLARIS: A Phase 1, Single Dose, Open-label Study of GNTI-122 in Adults With Recently Diagnosed Type 1 Diabetes (T1D)",
    "phase": "PHASE1",
    "status": "RECRUITING",
    "start_date": "2025-09-03",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06919354"
  },
  {
    "nct_id": "NCT06976619",
    "title": "The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People",
    "phase": "PHASE2",
    "status": "RECRUITING",
    "start_date": "2025-10-03",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06976619"
  },
  {
    "nct_id": "NCT07116434",
    "title": "Discovery Diabetes: A Pilot Randomized Controlled Trial",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-11",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07116434"
  },
  {
    "nct_id": "NCT05663515",
    "title": "EXCEED - A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs",
    "phase": "Unknown",
    "status": "RECRUITING",
    "start_date": "2024-09-30",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT05663515"
  },
  {
    "nct_id": "NCT06752928",
    "title": "A Randomized Controlled Trial Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-05-12",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06752928"
  },
  {
    "nct_id": "NCT07212075",
    "title": "Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups",
    "phase": "Unknown",
    "status": "RECRUITING",
    "start_date": "2025-01-01",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07212075"
  },
  {
    "nct_id": "NCT07209930",
    "title": "Inter- and Intraindividual Variability of the Acute Glucose Response to Exercise in Healthy Adults and People Living With Type 1 Diabetes: A Cross-over Replicate Trial",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-01-28",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07209930"
  },
  {
    "nct_id": "NCT06812988",
    "title": "A 52-week Randomized, Double-blind, Placebo-controlled, Multi-center Phase 2a Study Assessing Safety and Efficacy of SAR442970, a Dual Anti-TNF-\u03b1 and Anti-OX40L NANOBODY\u00ae Molecule, for Preservation of Pancreatic \u03b2-cell Function in Adults and Adolescents With Recently Diagnosed Type 1 Diabetes",
    "phase": "PHASE2",
    "status": "RECRUITING",
    "start_date": "2025-02-28",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06812988"
  },
  {
    "nct_id": "NCT07000149",
    "title": "A Phase Ib/III Randomized, Multicenter, Global Study of Volrustomig Plus Casdatifan or Volrustomig Monotherapy Versus Nivolumab Plus Ipilimumab as First-line Treatment for Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)",
    "phase": "PHASE3",
    "status": "RECRUITING",
    "start_date": "2025-07-28",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07000149"
  },
  {
    "nct_id": "NCT03228732",
    "title": "The Effects of the Selective Serotonin Reuptake Inhibitor, Fluoxetine and/or DHEA, on Neuroendocrine, Autonomic Nervous System and Metabolic Counterregulatory Responses During Repeated Hypoglycemia in T1DM Individuals",
    "phase": "EARLY_PHASE1",
    "status": "RECRUITING",
    "start_date": "2017-12-19",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT03228732"
  },
  {
    "nct_id": "NCT05626712",
    "title": "Clinical Trial to Evaluate the Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes (CREATE-1)",
    "phase": "PHASE1",
    "status": "RECRUITING",
    "start_date": "2023-04-07",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT05626712"
  },
  {
    "nct_id": "NCT07195045",
    "title": "Thai Version of PainPREDICT: Translation, Validation, and Mobile Application Development for Screening Painful Diabetic Neuropathy in Diabetes Patients",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-08-28",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07195045"
  },
  {
    "nct_id": "NCT06704672",
    "title": "Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range of 70 - 180 mg/dl Compared to SMBG",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-04-14",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06704672"
  },
  {
    "nct_id": "NCT06461065",
    "title": "Evaluation of Neurodevelopmental Trajectories in Children According to the Glycemic Profile Associated With Different Early Treatment Modalities in Children With Type 1 Diabetes (T1DM)",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-02-20",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06461065"
  },
  {
    "nct_id": "NCT06739811",
    "title": "Phoenix: Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-03-26",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06739811"
  },
  {
    "nct_id": "NCT06945406",
    "title": "A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes",
    "phase": "PHASE1",
    "status": "RECRUITING",
    "start_date": "2025-05-16",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06945406"
  },
  {
    "nct_id": "NCT06516614",
    "title": "Sleep Promoting Intervention to Improve Diabetes Outcomes and Executive Function in Adolescents With T1D",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2024-09-18",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06516614"
  },
  {
    "nct_id": "NCT06985862",
    "title": "Development of Artificial Intelligence Tools for the Detection of Stress Markers and Consideration of Stress States in the Monitoring of Subjects With Type 1 Diabetes",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-09-03",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06985862"
  },
  {
    "nct_id": "NCT07020936",
    "title": "Safety and Feasibility Testing of AIDANET in Children Age 6-13 Years",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-07-21",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07020936"
  },
  {
    "nct_id": "NCT07199946",
    "title": "A Phase I/II Double-blind, Randomized, Placebo-controlled Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving Verapamil",
    "phase": "PHASE1",
    "status": "RECRUITING",
    "start_date": "2025-08-06",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07199946"
  },
  {
    "nct_id": "NCT04187443",
    "title": "A Multicenter, Open-label, Dose Escalation Study Assessing the Safety and Treatment Effects of MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema",
    "phase": "PHASE1",
    "status": "RECRUITING",
    "start_date": "2020-06-02",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT04187443"
  },
  {
    "nct_id": "NCT06896045",
    "title": "Multicenter Study Evaluating the Relationship Between Perceived Daily Stress Level and Glycemic Level in Subjects With Type 1 Diabetes",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-04-22",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06896045"
  },
  {
    "nct_id": "NCT07185555",
    "title": "Applying Very Low Calorie Ketogenic Diet to the Treatment of Obesity in People With Type 1 Diabetes on Intensive Insulin Therapy Using Automated Insulin Delivery System",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-01-16",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07185555"
  },
  {
    "nct_id": "NCT05463289",
    "title": "Implementing Digital Retinal Exams Into Comprehensive Pediatric Diabetes Care",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2022-07-11",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT05463289"
  },
  {
    "nct_id": "NCT06575426",
    "title": "A Phase I/IIa, Single Site, Open-Label, Ascending Dose Study to Evaluate the Safety and Efficacy of OPF-310 [Encapsulated Porcine Islet Cells for Xenotransplantation] in Subjects With Type 1 Diabetes Mellitus",
    "phase": "PHASE1",
    "status": "RECRUITING",
    "start_date": "2025-06-10",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06575426"
  },
  {
    "nct_id": "NCT06706284",
    "title": "Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes",
    "phase": "PHASE4",
    "status": "RECRUITING",
    "start_date": "2025-04-11",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06706284"
  },
  {
    "nct_id": "NCT06280703",
    "title": "A Three-Part, Randomized, Double-Blind (Part A) and Open-Label (Part B and Part C), Multi-Dose, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus",
    "phase": "PHASE1",
    "status": "RECRUITING",
    "start_date": "2024-05-15",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06280703"
  },
  {
    "nct_id": "NCT06982859",
    "title": "A Phase 1, Investigator- and Participant-Blinded Study to Evaluate the Effect of Retatrutide on \u03b1- and \u03b2- Cell Function and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus",
    "phase": "PHASE1",
    "status": "RECRUITING",
    "start_date": "2025-06-02",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06982859"
  },
  {
    "nct_id": "NCT06069583",
    "title": "Using the Support Online Platform for Self-management Education of Adults Living With Type 1 Diabetes as Part of Usual Care or Independently: an Implementation Study",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2024-05-05",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06069583"
  },
  {
    "nct_id": "NCT05910840",
    "title": "Support-t, an Online Training and Peer Support Platform to Accompany Youth Living With Type 1 Diabetes Transitioning to Adult Healthcare",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2024-10-07",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT05910840"
  },
  {
    "nct_id": "NCT07160257",
    "title": "A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and \u03b2-cell Function in Participants With Type 2 Diabetes Mellitus",
    "phase": "PHASE1",
    "status": "RECRUITING",
    "start_date": "2025-08-05",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07160257"
  },
  {
    "nct_id": "NCT07177404",
    "title": "Surveying Experiences and Lifestyle Effects in Choosing Technology and Hybrid Closed Loop in Type 1 Diabetes",
    "phase": "Unknown",
    "status": "RECRUITING",
    "start_date": "2025-09",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07177404"
  },
  {
    "nct_id": "NCT05594563",
    "title": "TArgeting Type 1 Diabetes Using POLyamines (TADPOL): A Randomized, Double-Masked, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of Difluoromethylornithine (DFMO) to Preserve Insulin Production in Type 1 Diabetes",
    "phase": "PHASE2",
    "status": "RECRUITING",
    "start_date": "2023-03-14",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT05594563"
  },
  {
    "nct_id": "NCT06452654",
    "title": "Anti-viral Action Against Type 1 Diabetes Autoimmunity",
    "phase": "PHASE4",
    "status": "RECRUITING",
    "start_date": "2024-05-08",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06452654"
  },
  {
    "nct_id": "NCT06880835",
    "title": "INHALE-AIDEx: A Randomized Crossover Trial Evaluating the Effect of Inhaled Technosphere Insulin (Afrezza\u00ae) vs Rapid Acting Analogue Insulin on Exercise-Induced Hypoglycemia in Adults With Type 1 Diabetes Using Automated Insulin Delivery",
    "phase": "NA",
    "status": "RECRUITING",
    "start_date": "2025-06-05",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06880835"
  },
  {
    "nct_id": "NCT06685185",
    "title": "A Study Investigating Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes",
    "phase": "PHASE1",
    "status": "RECRUITING",
    "start_date": "2024-11-12",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT06685185"
  },
  {
    "nct_id": "NCT07052292",
    "title": "DuraTouch\u00ae - Post-Market Clinical Follow-up (PMCF) Study in a Real-world Setting",
    "phase": "Unknown",
    "status": "RECRUITING",
    "start_date": "2025-07-01",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07052292"
  },
  {
    "nct_id": "NCT07076199",
    "title": "A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes",
    "phase": "PHASE3",
    "status": "RECRUITING",
    "start_date": "2025-08-11",
    "priority": "HIGH",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT07076199"
  },
  {
    "nct_id": "NCT05936242",
    "title": "Evaluation of the INteraction Between Diet, microbiomE and Epigenetic Towards Personalized Interventions in Type 1 Diabetes (IN-DEEP Study)",
    "phase": "Unknown",
    "status": "RECRUITING",
    "start_date": "2021-05-18",
    "priority": "MEDIUM",
    "source": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/study/NCT05936242"
  }
]